Purdue Pharma L.P. to Present Data From Clinical Program for Butrans(TM) (buprenorphine) Transdermal System CIII at PAINWeek 2010 - Health News - redOrbit
Links shared publicly online about this topic.
- 885total visits
Purdue Pharma L.P. to Present Data From Clinical Program for Butrans(TM) (buprenorphine) Transdermal System CIII at PAINWeek 2010 - Health News - redOrbit
STAMFORD, Conn., Sept. 9 /PRNewswire/ -- Purdue Pharma L.P. will present data from the clinical program for Butrans(TM) (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek 2010, September 8-10 in Las Vegas. Butrans recently received marketing approval from the U.S.
View full resource at redorbit.com
Tags: Conn Syndrome, Pharma, Healthy Living, News, Butrans
Most Recently Shared on September 9, 2010 at 7:19 pm By:
Purdue Pharma L.P. to Present Data From Clinical Program for Butrans(TM) (buprenorphine) Transdermal System CIII a... http://bit.ly/cAAEEW
Advertisement
